Literature DB >> 23592542

Successes and shortcomings of polio eradication: a transmission modeling analysis.

Bryan T Mayer1, Joseph N S Eisenberg, Christopher J Henry, M Gabriela M Gomes, Edward L Ionides, James S Koopman.   

Abstract

Polio eradication is on the cusp of success, with only a few regions still maintaining transmission. Improving our understanding of why some regions have been successful and others have not will help with both global eradication of polio and development of more effective vaccination strategies for other pathogens. To examine the past 25 years of eradication efforts, we constructed a transmission model for wild poliovirus that incorporates waning immunity (which affects both infection risk and transmissibility of any resulting infection), age-mediated vaccination rates, and transmission of oral polio vaccine. The model produces results consistent with the 4 country categories defined by the Global Polio Eradication Program: elimination with no subsequent outbreaks; elimination with subsequent transient outbreaks; elimination with subsequent outbreaks and transmission detected for more than 12 months; and endemic polio transmission. Analysis of waning immunity rates and oral polio vaccine transmissibility reveals that higher waning immunity rates make eradication more difficult because of increasing numbers of infectious adults, and that higher oral polio vaccine transmission rates make eradication easier as adults become reimmunized. Given these dynamic properties, attention should be given to intervention strategies that complement childhood vaccination. For example, improvement in sanitation can reduce the reproduction number in problematic regions, and adult vaccination can lower adult transmission.

Entities:  

Keywords:  immunity; immunization programs; infectious disease transmission; mathematical model; poliomyelitis; poliovirus; poliovirus vaccines; vaccination

Mesh:

Substances:

Year:  2013        PMID: 23592542      PMCID: PMC3664334          DOI: 10.1093/aje/kws378

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  32 in total

1.  Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.

Authors:  T M Herremans; J H Reimerink; A M Buisman; T G Kimman; M P Koopmans
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

Review 2.  A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future.

Authors:  Radboud J Duintjer Tebbens; Mark A Pallansch; Olen M Kew; Victor M Cáceres; Roland W Sutter; Kimberly M Thompson
Journal:  Am J Epidemiol       Date:  2005-07-13       Impact factor: 4.897

Review 3.  Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature.

Authors:  J P Alexander; H E Gary; M A Pallansch
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

4.  Long-lasting poliovirus-neutralizing antibodies among Argentinean population immunized with four or five oral polio vaccine doses 1 month to 19 years previously.

Authors:  Silvia V Nates; Laura C Martinez; Patricia A Barril; Leonardo J Ferreyra; Miguel O Giordano; Gisela Masachessi; Maria Beatriz Isa
Journal:  Viral Immunol       Date:  2007       Impact factor: 2.257

5.  Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.

Authors:  Frithjofna Abbink; Anne M Buisman; Gerda Doornbos; Jan Woldman; Tjeerd G Kimman; Marina A E Conyn-van Spaendonck
Journal:  J Infect Dis       Date:  2005-02-10       Impact factor: 5.226

6.  Immunity to poliovirus among children and the elderly in north-east Italy.

Authors:  S Majori; V Baldo; A Poli; M Riolfatti; F Alborino; C Bonello; S Frau; T Baldovin; A Dal Zotto; G Romano; R Trivello
Journal:  J Prev Med Hyg       Date:  2006-03

7.  Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children.

Authors:  R W Sutter; P A Patriarca; S Brogan; P G Malankar; M A Pallansch; O M Kew; A G Bass; S L Cochi; J P Alexander; D B Hall
Journal:  Lancet       Date:  1991-09-21       Impact factor: 79.321

8.  Persistence of immunity to poliomyelitis among a southern population that received four doses of OPV 5 to over 15 years before.

Authors:  M Triassi; G Ribera; L Barruffo; S Barbone; E Medda; M E Grandolfo
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

9.  Age differences in immunity against wild and vaccine strains of poliovirus prior to the 1988 outbreak in Israel and response to booster immunization.

Authors:  M S Green; R Handsher; D Cohen; J L Melnick; R Slepon; E Mendelsohn; Y L Danon
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

10.  Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.

Authors:  T A Swartz; M S Green; R Handscher; D Sofer; M Cohen-Dar; T Shohat; S Habib; E Barak; Z Dror; E Somekh; T Peled-Leviathan; R Yulzari; A Libling; E Mendelson; L M Shulman
Journal:  Vaccine       Date:  2008-01-07       Impact factor: 3.641

View more
  12 in total

Review 1.  Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): clues and pitfalls in the pediatric background.

Authors:  Susanna Esposito; Elisabetta Prada; Maria Vincenza Mastrolia; Giusyda Tarantino; Claudio Codecà; Donato Rigante
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  Infectious disease: Polio eradication hinges on child health in Pakistan.

Authors:  Zulfiqar Ahmed Bhutta
Journal:  Nature       Date:  2014-07-17       Impact factor: 49.962

Review 3.  Quantitative Microbial Risk Assessment and Infectious Disease Transmission Modeling of Waterborne Enteric Pathogens.

Authors:  Andrew F Brouwer; Nina B Masters; Joseph N S Eisenberg
Journal:  Curr Environ Health Rep       Date:  2018-06

4.  Epidemiology of the silent polio outbreak in Rahat, Israel, based on modeling of environmental surveillance data.

Authors:  Andrew F Brouwer; Joseph N S Eisenberg; Connor D Pomeroy; Lester M Shulman; Musa Hindiyeh; Yossi Manor; Itamar Grotto; James S Koopman; Marisa C Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-18       Impact factor: 11.205

5.  Predictive spatial risk model of poliovirus to aid prioritization and hasten eradication in Nigeria.

Authors:  Alexander M Upfill-Brown; Hil M Lyons; Muhammad A Pate; Faisal Shuaib; Shahzad Baig; Hao Hu; Philip A Eckhoff; Guillaume Chabot-Couture
Journal:  BMC Med       Date:  2014-06-04       Impact factor: 8.775

6.  Quantifying the impact of expanded age group campaigns for polio eradication.

Authors:  Bradley G Wagner; Matthew R Behrend; Daniel J Klein; Alexander M Upfill-Brown; Philip A Eckhoff; Hao Hu
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

7.  The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission.

Authors:  Kimberly M Thompson; Radboud J Duintjer Tebbens
Journal:  BMC Infect Dis       Date:  2015-09-17       Impact factor: 3.090

8.  The potential impact of expanding target age groups for polio immunization campaigns.

Authors:  Radboud J Duintjer Tebbens; Dominika A Kalkowska; Steven G F Wassilak; Mark A Pallansch; Stephen L Cochi; Kimberly M Thompson
Journal:  BMC Infect Dis       Date:  2014-01-29       Impact factor: 3.090

9.  Applying the Concept of Peptide Uniqueness to Anti-Polio Vaccination.

Authors:  Darja Kanduc; Candida Fasano; Giovanni Capone; Antonella Pesce Delfino; Michele Calabrò; Lorenzo Polimeno
Journal:  J Immunol Res       Date:  2015-10-19       Impact factor: 4.818

10.  Silent circulation of poliovirus in small populations.

Authors:  Celeste Vallejo; James Keesling; James Koopman; Burton Singer
Journal:  Infect Dis Model       Date:  2017-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.